Pandion Therapeutics Inc. (PAND) Social Stream
Pandion Therapeutics Inc (PAND) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PAND.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 2 | $60 | $60 | $60 | $60.05 | -0.08% |
The Trend in the Analyst Price Target
Over the past 79 days, PAND's average price target has gone up $34.33.
Over the past 236 days, PAND's average upside potential has been 30.09%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2020-08-12 | 4 | 29 | 24 | 26.50 | 18.85 | 40.58% |
| 2020-11-27 | 4 | 29 | 24 | 26.50 | 17.28 | 53.36% |
| 2020-12-01 | 4 | 29 | 24 | 26.50 | 17.32 | 53% |
| 2020-12-26 | 4 | 29 | 24 | 26.50 | 15.42 | 71.85% |
| 2021-01-02 | 4 | 29 | 24 | 26.50 | 14.85 | 78.45% |
| 2021-01-09 | 3 | 28 | 24 | 25.67 | 17.54 | 46.35% |
| 2021-01-16 | 3 | 28 | 24 | 25.67 | 19.09 | 34.47% |
| 2021-01-21 | 3 | 28 | 24 | 25.67 | 18.01 | 42.53% |
| 2021-02-27 | 2 | 60 | 25 | 42.50 | 60.20 | -29.4% |
| 2021-03-06 | 2 | 60 | 60 | 60.00 | 59.89 | 0.18% |
| 2021-03-10 | 2 | 60 | 60 | 60.00 | 60.03 | -0.05% |
| 2021-04-03 | 2 | 60 | 60 | 60.00 | 60.05 | -0.08% |
| 2021-04-05 | 2 | 60 | 60 | 60.00 | 60.05 | -0.08% |
PAND Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 2 | 0 | 0 | 2 |
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- Pandion Therapeutics Inc's variance in analysts' estimates is less than just about 100% of all US stocks.
- The upside potential (average analyst target price relative to current price) of PAND is greater than 6.14% of Pharmaceutical Products stocks.
- The average analyst price target of PAND is greater than 91.13% of stocks in the small market cap category.
- The number of analysts covering the stock of PAND is higher than 13.87% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Pandion Therapeutics Inc are CBPO, RGLS and LFVN.
Make investment decisions regarding PAND using the data that counts. Try POWR Ratings for free.